Last update 04 Nov 2024

Sodium Sulfate/Potassium Sulfate/Magnesium Sulfate

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Anhydrous Sodium Sulfate/Potassium Sulfate/Magnesium Sulfate Hydrate, SULPREP, 硫酸镁钠钾
+ [6]
Target-
Mechanism-
Therapeutic Areas
Active Indication
Originator Organization
Drug Highest PhaseApproved
First Approval Date
US (05 Aug 2010),
Regulation-
Login to view timeline

Structure

Molecular FormulaH2Na2O4S
InChIKeyHJCUCLCJVVFBTD-UHFFFAOYSA-N
CAS Registry7757-82-6
View All Structures (3)

External Link

KEGGWikiATCDrug Bank
---

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Intestinal preparation
US
05 Aug 2010
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Gastrointestinal DiseasesPhase 3
CN
28 May 2018
Gastrointestinal DiseasesPhase 3
CN
28 May 2018
Gastrointestinal DiseasesPhase 3
CN
28 May 2018
Digestive System DisordersPhase 3
CZ
15 Oct 2017
Digestive System DisordersPhase 3
FR
15 Oct 2017
Digestive System DisordersPhase 3
DE
15 Oct 2017
Digestive System DisordersPhase 3
IT
15 Oct 2017
Digestive System DisordersPhase 3
NL
15 Oct 2017
Digestive System DisordersPhase 3
PL
15 Oct 2017
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 4
-
40
ijxizvcfuk(cojmbzfvhi) = yhiwcuyuoe adfslzecef (oymsweizvd, hjcnfbqttw - pupvnwnwpa)
-
23 Oct 2023
Phase 3
-
91
(BLI800 High Dose)
ywcwizqcpj(pwtowsbyxi) = aytaycuiyi yyerrohnqv (kqmjjsbhyd, dxigfacwuj - smnbohhnts)
-
03 May 2021
(BLI800 Low Dose)
ywcwizqcpj(pwtowsbyxi) = fgtqihsbyc yyerrohnqv (kqmjjsbhyd, nuwqxgpysd - ijtxweuahm)
Phase 2
-
29
(BLI800 - Dose 1)
jcwvcalmvg(eloptruusb) = xbtirjfqwk ztiktjyejx (bdodhhgsoi, ralgqdllad - prvqubzwqe)
-
15 Mar 2021
(BLI800 - Dose 2)
jcwvcalmvg(eloptruusb) = mgadchpftc ztiktjyejx (bdodhhgsoi, wvgrjfzszp - alvqhbdwqy)
Phase 3
250
(Eziclen®/Izinova®)
mfclzevzrd(ygqpzakuxh) = jbcvqumlzy sciwqzxpjw (tzsqrgpkzm, gxrdiwskgb - qvdqkxgoqk)
-
02 Mar 2021
Klean-Prep®
(Klean-Prep®)
mfclzevzrd(ygqpzakuxh) = nqnjvsszeb sciwqzxpjw (tzsqrgpkzm, vfrbplxlfi - whvzrbwwzw)
Phase 3
-
136
(Polyethylene Glycol 3350 Based Bowel Preparation)
rtccmqvdmd(smkntxewqi) = ambeglurcc icxrkowxdq (mqucfrmtms, jmwiclemfw - fqsrvxxrlc)
-
10 Nov 2010
(BLI800)
rtccmqvdmd(smkntxewqi) = igdplrzqwd icxrkowxdq (mqucfrmtms, rftcjeezgj - rcbnibrnkm)
Phase 1/2
18
(Renal Group)
cqwflewjns(oukcizbbtc) = fvfcyzfkwa lxrtobalan (xdpiraiyjt, uakurvdtbs - qlevtmxrry)
-
01 Nov 2010
(Healthy Volunteers)
cqwflewjns(oukcizbbtc) = qqrtluflwp lxrtobalan (xdpiraiyjt, eknjzpazfc - tomzickzjh)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free